Optimization Of The Post-Cataract Patient Journey: Ai-Driven Teleconsultation.

To assess the effectiveness, safety, and acceptability of Ufonia’s Dutch ophthalmological response agent (Dora) for postoperative cataract surgery patients. Dora is designed to identify postoperative cataract surgery patients requiring further assessment.

University Eye Clinic Maastricht, Maastricht University Medical Center (MUMC+), the Netherlands.

A single-center prospective trial was conducted at the University Eye Clinic Maastricht UMC+. Subjects scheduled for cataract surgery were included. The patients received a telephone call from Dora at one week and four weeks after surgery, in addition to regular cataract care. Dora calls were supervised by a clinician, and this supervised decision-making was compared with clinical decision-making by Dora. At the end of each Dora conversation, patients were asked to provide a Net Promotor Score (NPS).

Sixty-three patients scheduled for cataract surgery were included and received Dora calls. These patients had a mean age of 72±6 years and underwent surgery on one or both eyes. The overall accuracy for symptom evaluation of the Dora conversation was high, with a sensitivity of 92% and specificity of 95%. The sensitivity and specificity for clinical decision-making of Dora were 100% and 73%, respectively. Patients rated the conversation with a mean NPS of 7.3.

The Dutch ophthalmological response agent for patients who underwent cataract surgery demonstrated high sensitivity for symptom evaluation and clinical decision-making when compared to supervised outcomes. These performance outcomes of Dora suggest its potential as a reliable screening tool for the follow-up of post-cataract patients.